Perspective and Science Perspective

Chinese landscape painting is the same as Chinese poetry, "the realm is the highest, and the realm is its own high standard." Using Cavalier Perspective to look at the science, look at art, or the fusion of the two, this may be another method, or it can be called another state.

MORE
OUR VALUE

Our Values Medical technology is an exciting field because it directly improves human health and prolongs human life. No other field can be so closely related to every person. Medical technology is the most challenging field. The creation and application of medical science and technology products must face tons of challenges such as complex human body function, systematic basic research, fine design and development, in-depth demand and market analysis, and also need to solve the complex relationship among various stakeholders, supervision, and financing.

MORE
Biomedical design: a positive perspective to solve complex problems

Biomedical research and development are rooted in health consumers, which means that the real demand is the original motivation of this innovation, which may be different from many basic sciences, such as mathematics and theoretical physics.

MORE
Genomic Medicine：the Era of Single Cell Omics

Derived and developed from Genetics in the Nineteenth century, Genomics has experienced several waves of the paradigm shifts which mostly attributed the development and integration of theories and technology innovation. w, the fundamental motivation of the genomic medicine brings out new insights and solution to diseases and serves for patients.

MORE
PEOPLE INSIGHT

Heart failure is the most challenging field in cardiovascular disease. In recent years, the treatment of heart failure has made great progress. However, there is still a huge unmet need for treatment. Here, associate researcher Yang Ke of Ruijin Hospital affiliated to Shanghai Jiaotong University will share his thoughts and insights.

MORE
What we do

CAVALIER PERSPECTIVE is an institution and community to analyze and share our knowledge and insights on medical science, and empower our scientists and innovators in translational medical research institutions medical industries for driving innovation on knowledge, technology, and brand.

LATEST FROM PERSPECTIVE

Artificial Intelligence

AI and Clinical Research: the Possibility of Decision Accuracy

Clinical research is the test of the medications to achieve real application. After leaving the limited space of cells and the ideal animal models, the effect and safety of the medications after entering the human body is a complex issue, which is affected by many factors such as individual biology,...

2021-06-27

Ageing

Aging: a kind of underlying logic for understanding diseases

It seems that how Alzheimer's disease occurs and how to choose treatment has always been a problem for countless people. It is not only a logical problem of chicken or egg first, but also a philosophical problem of appearance and essence. In addition to the treatment dilemma that makes scientists sc...

2021-06-25

Cancer

Tumor metastasis: the secret of time and space

For the treatment of primary tumors, there are many methods: surgical resection as the first-line treatment, combined with radiotherapy, chemotherapy, and targeted therapy as the back-line or adjuvant treatment. These methods have formed a paradigm for the treatment of solid tumors. However, for met...

2021-06-24

Pharmaceutical

Inspiration of film to pharmaceutical industry

In 2021, the article of The Economist "Go small: The new economics of blockbusters" talked that (1), during the period of COVID-19, the scarcity of movie blockbusters is reshaping box office economics. It may point to another option, that is with the reduction of large production, the productio...

2021-06-23

Biotechnology

Which biotechnology and companies continue to receive attention？

The sudden COVID-19 epidemic has brought the largest recession to the global economy since World War II. A report so-called the target Guardian report released from Bill & Melinda Gates Foundation shows that the global GDP loss is twice that of the 2008 economic crisis. Data from ...

2021-06-23

Kinases

Kinase drugs: the cornerstone in the future

Kinase can add phosphate group (PO43-) to target protein, lipid and nucleic acid molecules. There are at least 500 genes encoding kinases in the human genome. Among them, protein kinase can phosphorylate serine, threonine, tyrosine and other amino acids by adding phosphate groups to protein.

2021-06-20
MORE

© 2022 CAVALIER PERSPECTIVE. All rights reserved. 沪ICP备2021024167号-1


Disclaimer and Agreement

CAVALIER PERSPECTIVE is a medical technology knowledge and opinion management organization. CAVALIER PERSPECTIVE mainly analyzes and shares medical technology knowledge and opinions, and helps scientists engaged in translational medicine research and entrepreneurs in biomedical companies to carry out knowledge innovation, technological innovation and product innovation. Currently, it is unable to provide consulting and business services for most organizations and customers. The website provides information for potential customers, such as researchers, scientists, students, business managers, and industry-related personnel. In any case, any information contained on this website shall not be sold for commercial purposes. This website does not contain any unauthorized data and patents of customers. Some research reports and data provided on this website may not be available to the public without authorization.

To view this content, in addition to using the CAVALIER PERSPECTIVE terms and privacy policy, you must agree to the following terms:

I confirm and agree to CAVALIER PERSPECTIVE:

  • I entered this website only to obtain general information about CAVALIER PERSPECTIVE and not for any other purpose.
  • I understand that the personal data provided by CAVALIER PERSPECTIVE is not open to the public.
  • I understand that certain research report materials on this website will only be provided to a small number of people and organizations that meet the specified standards.
  • I understand that this website has not been reviewed or approved, submitted or otherwise provided by any government or similar agency, and the purpose of this website is only to provide to the public who have a legitimate interest in such information for reasons unrelated to investment Limited information.
  • I understand that when CAVALIER PERSPECTIVE provides third-party information, CAVALIER PERSPECTIVE usually does not have a verified statement made by a third party, and the presentation of information may omit important information.
  • I know that third-party materials, such as provided by on-site interviews or written in their own name, CAVALIER PERSPECTIVE usually does not make changes to these materials on the premise of determining the relevant topics. With the informed consent of the third party, they may be individually based on the semantic context. Sentence editing, which may include providing historical and professional background.
  • The content of CAVALIER PERSPECTIVE has proprietary intellectual property rights or third-party materials, including interviews and licensors of writing, etc. I will guarantee that I will not directly or indirectly copy, modify, rewrite, or create derivative works, including articles, social media , Publish, display, redistribute, disclose or provide content. For all or part of the website content, any content used for commercial purposes requires the written consent of CAVALIER PERSPECTIVE.

By registering the following my information and clicking "Agree", I guarantee that I have read:

Agree